Severe congenital neutropenia: genetics and pathogenesis

Area of Science:

• Hematology
• Genetics
• Cell Biology

Background:

• Severe congenital neutropenia (SCN) is a rare disorder marked by low neutrophil counts, leading to recurrent infections.
• SCN is associated with impaired bone marrow progenitor cell function, including reduced proliferation and increased apoptosis.
• Genetic analysis has implicated mutations in the neutrophil elastase (NE) gene in many SCN cases.

Purpose of the Study:

• To investigate the role of neutrophil elastase (NE) gene mutations in the pathogenesis of severe congenital neutropenia (SCN).
• To determine the functional consequences of mutant NE expression on myeloid progenitor cells.
• To identify the source of SCN in a cohort of children from a single sperm donor.

Main Methods:

• Sequencing analysis of the NE gene in SCN patients.
• In vitro studies assessing the effect of wild-type and mutant NE expression on HL-60 progenitor cell apoptosis.
• Genomic DNA studies to trace the origin of SCN in affected families.

Main Results:

• Heterozygous mutations in the NE gene were identified in numerous SCN patients.
• Expression of mutant NE, but not wild-type NE, significantly accelerated apoptosis in human HL-60 progenitor cells.
• Genomic DNA analysis successfully identified the sperm donor responsible for SCN in five affected children.

Conclusions:

• Mutant NE expression directly contributes to the impaired survival of bone marrow myeloid progenitor cells, causing neutropenia in SCN.
• The neutrophil elastase (NE) gene is a key factor in the development of severe congenital neutropenia.
• Genetic investigations, including DNA studies, are crucial for understanding disease transmission and identifying causative factors in rare hematological disorders.